Search hospitals > New York > Albany

Albany Medical Center

Claim this profile
Albany, New York 12208
Global Leader in Cancer
Global Leader in Brain Tumor
Conducts research for Neuroblastoma
Conducts research for Solid Tumors
Conducts research for Rhabdomyosarcoma
343 reported clinical trials
38 medical researchers
Photo of Albany Medical Center in AlbanyPhoto of Albany Medical Center in AlbanyPhoto of Albany Medical Center in Albany

Summary

Albany Medical Center is a medical facility located in Albany, New York. This center is recognized for care of Cancer, Brain Tumor, Neuroblastoma, Solid Tumors, Rhabdomyosarcoma and other specialties. Albany Medical Center is involved with conducting 343 clinical trials across 789 conditions. There are 38 research doctors associated with this hospital, such as Lauren Weintraub, MD, Robert Busch, Alexandra Paul, MD, and Sanjay Samy, MD.

Area of expertise

1Cancer
Global Leader
Albany Medical Center has run 43 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage I
RET
2Brain Tumor
Global Leader
Albany Medical Center has run 39 trials for Brain Tumor. Some of their research focus areas include:
Stage IV
Stage I
Stage II

Top PIs

Clinical Trials running at Albany Medical Center

Brain Tumor
Prostate Cancer
Testicular cancer
Leukemia
Cancer
Wilms Tumor
Stroke
Neuroblastoma
Burkitt Lymphoma
Dystonia
Image of trial facility.

Selumetinib vs. Chemotherapy

for Brain Cancer

This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Image of trial facility.

DAY101 vs. Chemotherapy

for Pediatric Brain Cancer

This trial is testing tovorafenib, a medication given alone, in children with a specific type of brain tumor. The drug works by blocking a protein that helps cancer cells grow.
Recruiting2 awards Phase 3
Image of trial facility.

Lower Radiotherapy Dose

for Brain Tumors

This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous system (CNS) germinomas. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Researchers want to see if lowering the dose of standard radiotherapy (RT) after chemotherapy can help get rid of CNS germinomas with fewer long-term side effects.
Recruiting1 award Phase 210 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Albany Medical Center?
Where is Albany Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Albany Medical Center accept?
What awards or recognition has Albany Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security